Fabio Ciceri

Also affiliated with Istituti di Ricovero e Cura a Carattere Scientifico, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

3.3Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

Neurology(2021)10.1212/wnl.0000000000011461

Top 7%

3.3DataRank

Top 7%81 citations

Luca Massacesi, Matilde Inglese, Alice Mariottini, Marco Capobianco, Lucia Moiola +41 more

Papers

Driven by 14 papers — median percentile 93. Top paper: “Autoantibodies against type I IFNs in patients with life-threatening COVID-19”.

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Science(2020)10.1126/science.abd4585

N/A

11.9DataRank · unranked

2864 citations

Lindsey B. Rosen, Qian Zhang, Eleftherios Michailidis, Hans-Heinrich Hoffmann, Yu Zhang +95 more

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Blood(2020)10.1182/blood.2020007732

N/A

4.0DataRank · unranked

322 citations

Ibrahim Aldoss, Matthew C. Foster, Peter H. Sayre, Matthew J. Wieduwilt, Anjali S. Advani +43 more

Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

Neurology(2021)10.1212/wnl.0000000000011461

Top 7%

3.3DataRank

Top 7%81 citations

Luca Massacesi, Matilde Inglese, Alice Mariottini, Marco Capobianco, Lucia Moiola +41 more

A Case of Two Adult Brothers with Wiskott-Aldrich Syndrome, One Treated with Gene Therapy and One with HLA-Identical Hematopoietic Stem Cell Transplantation

Journal of Clinical Immunology(2022)10.1007/s10875-021-01157-6

N/A

1.0DataRank · unranked

11 citations

Francesca Ferrua, Pina Brianti, Jacopo Peccatori, Sarah Markel, Fabio Giglio +21 more

Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera

NEJM Evidence(2023)10.1056/evidoa2200335

N/A

0.601DataRank · unranked

54 citations

Alessandro Maria Vannucchi, Valerio De Stefano, Alessandra Carobbio, Arianna Ghirardi, Greta Carioli +33 more

Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency

Nature Medicine(2024)10.1038/s41591-023-02789-4

N/A

0.494DataRank · unranked

26 citations

Federica Barzaghi, Claudia Fossati, Paola M. V. Rancoita, Michela Gabaldo, Francesca Dionisio +49 more

The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

Research Square(2022)10.21203/rs.3.rs-1225906/v1

N/A

0.483DataRank · unranked

24 citations

Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot +95 more

The first case of COVID-19 treated with the complement C3 inhibitor AMY-101

Clinical Immunology(2020)10.1016/j.clim.2020.108450

N/A

0DataRank · unranked

297 citations

Annalisa Ruggeri, Antonio M. Risitano, Piera Angelillo, Despina Yancopoulou, Dimitrios C. Mastellos +7 more

Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy

Clinical Immunology(2020)10.1016/j.clim.2020.108598

N/A

0DataRank · unranked

265 citations

Bruno G. P. Pires da Silva, Benedito Antônio Lopes da Fonseca, Natasha Peixoto Fonseca, Maria Auxiliadora‐Martins, Sara Mastaglio +18 more

Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis

Neurology(2022)10.1212/wnl.0000000000206750

N/A

0DataRank · unranked

38 citations

Alessio Signori, Luca Massacesi, Alice Mariottini, Elvira Sbragia, Salvatore Cottone +47 more

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2200413119

N/A

0DataRank · unranked

196 citations

Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot +95 more

Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation

Blood Advances(2020)10.1182/bloodadvances.2020001499

N/A

0DataRank · unranked

62 citations

Dongyun Yang, Myriam Labopin, Boris V. Afanasyev, Emanuele Angelucci, Asad Bashey +21 more

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Science Immunology(2021)10.1126/sciimmunol.abl4340

N/A

0DataRank · unranked

634 citations

Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot, Jérémy Manry +95 more

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

Nature Communications(2021)10.1038/s41467-021-22958-8

N/A

0DataRank · unranked

381 citations

Massimiliano Secchi, Maria Franca Pirillo, Monica Tolazzi, Martina Borghi, Cristina Brigatti +15 more

Fabio Ciceri

Indexed papers

Top data-sharing exemplar

Papers